Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000215021

Medchemexpress LLC Phenylpropenamide derivative | 211364-06-6 | 98.4% | 488.33 g/mol | C22H22BrN3O5 | 5 MG
SDP

Catalog No. 5000215021
Encompass_Preferred

AT-130 is a phenylpropenamide-derived non-nucleoside inhibitor of hepatitis B virus (HBV) replication that inhibits viral DNA synthesis (EC50 = 0.13 μM). It is active against wild-type and certain mutant HBV strains and is intended for use as a research tool in antiviral and hepatoma cell studies.

  • Potent HBV replication inhibitor (EC50 = 0.13 μM).
  • Active against wild-type and certain mutant HBV strains.
  • High reported purity suitable for research applications.
  • Soluble in DMSO at 25 mg/mL; may require ultrasonication.
  • Recommended storage: powder -20°C; in solution -80°C (6 months) or -20°C (1 month).
  • Available in small solid quantities appropriate for lab-scale studies.

Catalog No. 50-002-15021 Supplier Medchemexpress LLC Supplier No. HY1000285MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

AT-130 is a phenylpropenamide-derived non-nucleoside inhibitor of hepatitis B virus (HBV) replication that inhibits viral DNA synthesis (EC50 = 0.13 μM). It is active against wild-type and certain mutant HBV strains and is intended for use as a research tool in antiviral and hepatoma cell studies.

  • Potent HBV replication inhibitor (EC50 = 0.13 μM).
  • Active against wild-type and certain mutant HBV strains.
  • High reported purity suitable for research applications.
  • Soluble in DMSO at 25 mg/mL; may require ultrasonication.
  • Recommended storage: powder -20°C; in solution -80°C (6 months) or -20°C (1 month).
  • Available in small solid quantities appropriate for lab-scale studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.